Clean Science & Technology Ltd. · NSE:CLEAN
Clean Science & Technology — Q4 FY2024 Earnings Presentation
21 slides from Clean Science & Technology's earnings presentation, May 15, 2024
Slide 1: Exchange filing cover letter for investor presentation
15.05.2024 To, BSE Limited National Stock Exchange of India Limited Phiroze JeeJeebhoy Towers, Exchange Plaza, Plot no. C/1, Dalal Street, G Block, Bandra-Kurla Complex Fort, Mumbai – 400 001 Bandra (E), Scrip Code: 543318 Mumbai - 400 051 Trading Symbol: CLEAN Subject: Investor Presentation. Dear S
Slide 2: Clean Science and Technology Ltd. Investor Presentation Q4 FY2024
Clean Science and Technology Ltd. Investor Presentation Q4 FY 2024 I MAY 2024
Slide 3: Safe Harbour
SAFE HARBOUR This investor presentation has been prepared by Clean Science and Technology Limited (“CSTL”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered o
Slide 4: Q4 FY2024 & FY2024 Update
Q4 FY 2024 & FY2024 Update
Slide 5: Q4 FY24 Update
Q4 FY24 UPDATE Volume led annual and sequential growth in revenue; EBITDA margins continue to be robust Revenue in INR Crore 234 248 237 217 188 181 195 225 Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q2 FY24 Q3 FY24 Q4 FY24 49.1% 46.1% 44.9% 44.4% 41.3% 42.4% 39.4% 39.8% 39.4% 37.9% 39.2% 33.1% 34.7% 3
Slide 6: Q4 FY24 and FY24 P&L Overview - Standalone
Q4 FY24 and FY24 P&L OVERVIEW - STANDALONE Progressive recovery in revenue continues; steady profitability margins for the quarter and full year P&L (INR Crore) Q4 FY2024 Q3 FY2024 Q-o-Q (%) Q4 FY2023 Y-o-Y (%) FY 2024 FY 2023 Y-o-Y (%) Sale of products 222.2 192.3 16% 214.4 4% 777.8 926.5 (16)% Oth
Slide 7: Revenue Profile – FY 2024
REVENUE PROFILE –FY 2024 Contribution from newer products increased REVENUE MIX BY SEGMENT REVENUE MIX BY GEOGRAPHY 13% 5% 11% 10% 28% 19% 22% 36% 35% 19% FY24 FY23 FY24 FY23 67% 70% 14% 16% 17% 16% Performance Pharma & Agro FMCG China India Europe Americas Row chemicals Intermediates chemicals ➢ Pe
Slide 8: FY24 Balance Sheet Overview - Standalone
FY24 BALANCE SHEET OVERVIEW - STANDALONE Healthy cash balance despite funding largest capex over last 2 years and increased payout ratio As at As at In INR Crore 31-March-2024 31-March-2023 Assets Non-current assets Fixed Assets 396.6 422.1 Capital work-in-progress 1.7 4.1 Right of use asset 3.8 3.9
Slide 9: Corporate presentation
Corporate presentation
Slide 10: Clean Science and Technology at a Glance
CLEAN SCIENCE AND TECHNOLOGY AT A GLANCE A brief Introduction about the Company ➢ One of the fastest growing and among the most profitable fine and specialty chemical companies globally. Among the largest manufacturers of certain specialty chemicals developed in-house. ➢ Among the few global organiz
Slide 11: Company Evolution
COMPANY EVOLUTION Continuous R&D and Innovation has led to new product launches on a consistent basis YEAR 2006 2009 2011 2014 2018 2020 2021 2022 2023 REVENUES (INR Crore) - 1 19 120 241 419 512 685 936 ➢ Commercialized plant to 2022 2023 manufacture P-BQ and TBHQ ➢ Commercialized unique 2020 ➢ Com
Slide 12: Diversified Product Profile Serving Critical End-User Industries
DIVERSIFIED PRODUCT PROFILE SERVING CRITICAL END-USER INDUSTRIES Largest capacity in the world for our flagship products PERFORMANCE PHARMA AND AGRO FMCG CHEMICALS INTERMEDIATES CHEMICALS MEHQ (Monomethyl Ether of Hydroquinone) Guaiacol 4-MAP (4-Methoxy Acetophenone) ➢ Used as polymerization inhibit
Slide 13: Key Differentiators That Add Value
KEY DIFFERENTIATORS THAT ADD VALUE Unique benefits that set our business apart from competition INNOVATION GLOBAL LEADERS PREFERRED PARTNER STATE-OF-THE-ART Strategic process innovation Among the largest OF CHOICE Multiple, automated and new product producers globally of Strong and long term manufac
Slide 14: Steadfast Focus on Research & Development
STEADFAST FOCUS ON RESEARCH & DEVELOPMENT Pioneered commercialization of catalytic reactions Research and Development team’s focus areas Enhance our existing catalyst Develop products with high demand Expand product portfolio in the 1 systems to further optimize yield 2 performance chemical segment
Slide 15: Cohesive and Technocrat Promoters
COHESIVE AND TECHNOCRAT PROMOTERS Strong visibility on longevity of Promoters’ engagement in the business Over 27 years of work experience in Over 17 years of experience in the the chemical industry. chemical industry. Previously worked as an Executive Director at Mangalam Drugs and Bachelor of Chem
Slide 16: Robust Corporate Governance
ROBUST CORPORATE GOVERNANCE Distinguished Board of Directors and reputed financial market participants underscore sound governance PROFILE OF NON-EXECUTIVE, INDEPENDENT DIRECTORS ON THE BOARD PRADEEP RATHI PROF. G. D. YADAV Sanjay Kothari Chairman and Non-Executive Director Non-Executive, Independen
Slide 17: Continued Commitment Towards Sustainability and ESG
CONTINUED COMMITMENT TOWARDS SUSTAINABILITY AND ESG Sustainability and ESG initiatives are embedded in our long term growth strategy ENVIRONMENT EMPATHY (E) SOCIAL RESPONSIBILITY (S) CORPORATE GOVERNANCE (G) ➢ Utilize resources efficiently, reduce waste ➢ Total contribution towards CSR activities ➢
Slide 18: Advanced Manufacturing Facilities Designed by In-House Engineering Team
ADVANCED MANUFACTURING FACILITIES DESIGNED BY IN-HOUSE ENGINEERING TEAM 3 independent functional units at Kurkumbh Industrial Area, Maharashtra with dedicated lines for each product UNIT 1 NO plant closure notice received from pollution 7 plants control board Total area – 30,000 sq.m All Units are I
Slide 19: Strong Financial Performance
STRONG FINANCIAL PERFORMANCE Resilient performance demonstrated over business cycles maintaining a debt free balance sheet REVENUE EBITDA & EBITDA% PAT & PAT% CAGR of 24% EBITDA CAGR of 31% PAT CAGR of 33% 393 419 512 685 936 136 185 259 300 403 98 140 198 229 304 44% 43% 33% 33% 51% 39% 44% 25% 33%
Slide 20: Our Key Growth Drivers
KEY GROWTH LEVERS Strategic initiatives and investments aimed at long term sustainable growth FOCUS ON ESG AND SIGNIFICANT SUSTAINABILITY GREENFIELD CAPEX Capitalise on our core philosophy Planned capex on track for of clean and green chemistry to commercialising new series of address opportunities
Slide 21: Thank You
THANK YOU For further information, please contact: PRATIK BORA Email: pratik@cleanscience.co.in Clean Science and Technology Limited Website: https://www.cleanscience.co.in/
Clean Science and Technology — Q4 FY2024 Earnings Presentation on 6ix